Back to 2015 Annual Meeting Posters
Early results of prospective randomized controlled trial MICSREVS - Minimally Invasive Cardiac Surgery REVascularization Strategy
Aliaksandr Ziankou, Mikalai Laiko, Kiryl Vykhrystsenka.
Vitebsk State Medical University, Vitebsk, Belarus.
OBJECTIVE: The minimally invasive multi-vessel coronary revascularization are still in the pipeline and are being established, which is why the basic comparative studies of immediate and, even more so, long-term results, are a matter of present and future research. We evaluated early results of prospective randomized controlled trial (RCT) MICSREVS (Minimally Invasive Cardiac Surgery REVascularization Strategy) - Comparative Effectiveness of the Minimally Invasive Coronary Artery Bypass Grafting (MICS-CABG) Versus Off Pump (OPCABG) and On Pump Coronary Artery Bypass Grafting (ONCABG).
METHODS: The RCT MICSREVS was started at our clinic in January 2014 (http://www.clinicaltrials.gov/show/NCT02047266). The trial design includes 150 patients, who divided in 3 groups of 50 peoples. In group I the MICS-CABG strategy is directed to perform multi-vessel arterial revascularization via the left mini-thoracotomy on the beating heart with aortic no-touch technique. A hybrid approach and parallel transfemoral cardiopulmonary bypass without cardioplegia are acceptable for achieving the required revascularization. In control groups II (OPCABG) and III (ONCABG) conventional surgery are performed via median sternotomy. Criteria of inclusion in our trial are multi-vessel coronary artery disease, II-IV Canadian Cardiovascular Society functional class of angina and patients at 1 month after acute myocardial infarction. Exclusion Criteria are previous CABG, single vessel disease and need for emergency revascularization. Randomization is carried out by the blind method ("envelopes"). As a primary outcome measures of the trial are accepted death from any cause and major adverse cardiac and cerebrovascular events (MACCE). Hospitalization period, 12 and 36 months after primary myocardial revascularization were planned as the control points. 76 patients are included in research at this moment. 30 patients were randomized to the group I, 24 and 22 patients - to the groups II and III respectively. Patient’s clinical characteristics did not differ significantly between treatment groups.
RESULTS: In treatment groups myocardial revascularization was successfully performed in all cases. There were no deaths from any cause and MACCE during hospitalization period. There were no cases of incomplete myocardial revascularization, technical difficulties and other complications.
CONCLUSIONS: The MICS-CABG strategy at inhospital point of RCT MICSREVS showed the good results comparable with results of conventional OPCABG and ONCABG.
Back to 2015 Annual Meeting Posters




